Literature DB >> 4056837

Acute hepatitis in a patient treated with carbamazepine.

D Galeone, G Lamontanara, D Torelli.   

Abstract

A case of serious acute hepatic damage probably induced by carbamazepine (CBZ) is described. A 4-year-old patient with generalized tonic-clonic seizures was started on CBZ after various ineffective therapies. On the 10th day of CBZ therapy, he was readmitted to the hospital because of reappearance of fits, and went into hepatic coma. On the hypothesis that he was suffering an acute toxic reaction to CBZ, the drug was withdrawn (the serum level was not toxic) and the patient was subjected to peritoneal dialysis. The patient was discharged after 15 days in general conditions similar to those preceding the comatose state. The type of hepatic damage revealed by the laboratory tests and the early appearance of the clinical symptoms with non-toxic serum CBZ levels support the hypothesis of an idiosyncratic reaction to CBZ.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 4056837     DOI: 10.1007/BF00313869

Source DB:  PubMed          Journal:  J Neurol        ISSN: 0340-5354            Impact factor:   4.849


  14 in total

1.  Idiosyncratic reactions to the antiepileptic drugs.

Authors:  H E Booker
Journal:  Epilepsia       Date:  1975-03       Impact factor: 5.864

2.  [STUDIES ON THE TOLERANCE AND EXCRETION OF A NEW ANTIEPILEPTIC].

Authors:  J FUEHR
Journal:  Arzneimittelforschung       Date:  1964-01

Review 3.  The role of theliver in drug metabolism.

Authors:  H Remmer
Journal:  Am J Med       Date:  1970-11       Impact factor: 4.965

4.  [The metabolism of carbamazapine (author's transl)].

Authors:  S Goenechea; E Hecke-Seibicke
Journal:  Z Klin Chem Klin Biochem       Date:  1972-03

Review 5.  Alkaline phosphatase.

Authors:  S Posen
Journal:  Ann Intern Med       Date:  1967-07       Impact factor: 25.391

6.  [Carbamazepine for the treatment of essential neuralgia of the trigeminal nerve].

Authors:  G Morello; F Pluchino
Journal:  Sist Nerv       Date:  1968 May-Jun

7.  Epoxides metabolically produced from some known carcinogens and from some clinically used drugs. I. Differences in mutagenicity.

Authors:  H R Glatt; F Oesch; A Frigerio; S Garattini
Journal:  Int J Cancer       Date:  1975-11-15       Impact factor: 7.396

Review 8.  Metabolism and Pharmacolinetics of Carbamazepine.

Authors:  P L Morselli; A Frigerio
Journal:  Drug Metab Rev       Date:  1975       Impact factor: 4.518

9.  Carbamazepine-induced jaundice.

Authors:  I D Ramsay
Journal:  Br Med J       Date:  1967-10-28

10.  Granulomatous hepatitis secondary to carbamazepine.

Authors:  M Levy; M W Goodman; B J Van Dyne; H W Sumner
Journal:  Ann Intern Med       Date:  1981-07       Impact factor: 25.391

View more
  3 in total

Review 1.  Risk-benefit assessment of carbamazepine in children.

Authors:  M N Seetharam; J M Pellock
Journal:  Drug Saf       Date:  1991 Mar-Apr       Impact factor: 5.606

2.  Transient cholestatic hepatitis in a neonate associated with carbamazepine exposure during pregnancy and breast-feeding.

Authors:  B Frey; G Schubiger; J P Musy
Journal:  Eur J Pediatr       Date:  1990-12       Impact factor: 3.183

3.  Modeling Epoxidation of Drug-like Molecules with a Deep Machine Learning Network.

Authors:  Tyler B Hughes; Grover P Miller; S Joshua Swamidass
Journal:  ACS Cent Sci       Date:  2015-06-09       Impact factor: 14.553

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.